The Impact of Anemia on Chronic Kidney Disease patients in the region of Al-khums City, Libya
DOI:
https://doi.org/10.65405/h4wjz889Keywords:
Anemia, Chronic kidney disease, Hemoglobin, Iron deficiency.Abstract
Anemia is known to be a common and clinically important cause of chronic kidney disease (CKD) With the progression of CKD, various factors can be attributed to a reduction in hemoglobin (Hb) levels, the method used in this research is analytical it is a cross-sectional type of research, which means that it has been conducted throughout a certain time with a specific population sample, The temporal scope of the research was conducted from September to December 2023, whereas the spatial scope was meant to allocate the place where the research was done, which is in Training Hospital Al-khums city , Libya. the sample was selected according to the medical history of the patients and only included those who have CKD ,The number of this sample was 200. There most of patient were 118 males and 82 females.and the age 51 to 60 year and level of hemoglobin (Hb) is almost patient is under low average, all the data items are valid and reliability statistics, Cronbach's alpha is > 0.01, however Urea and level of creatinine almost the patient's high average ,Blood glucose almost all the patients have a high average in the WBC the normal averages In the RBCs number of normal averages is lower than the high average from all population samples the test on blood platelets in the results are almost average for normal almost all patients who have anemia are directly affected by CKD.
Downloads
References
1. Moreno F, Gomez JML, Jofre R, Valderrabano F, Gonzalez L, Gorriz JL, et al. Nephrology dialysis transplantation quality of life in dialysis patients. A Spanish multicentre study. NDT. (1996) 11(Suppl 2):125–9. doi: 10.1093/ndt/11.supp2.125
2. Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano RCP. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. CurrMed Res Opin. (2006) 22:1929–37. doi: 10.1185/030079906X132541
3. Minutolo R, Conte G, Cianciaruso B, Bellizzi V, Camocardi A, De Paola L DNL. Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. Nephrol Dial Transplant. (2012) 27:2880–6. doi: 10.1093/ndt/gfs0
4. Astor BC, Coresh J, Heiss G, Pettitt D. Kidney function and anemia as risk factors for coronary heart disease and mortality: the atherosclerosis risk in communities (ARIC) study. Am Hear J. (2006) 151:492–500. doi: 10.1016/j.ahj.2005.03.055
5. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int. (2006) 69:560–4. doi: 10.1038/sj.ki.5000105
6. Nissenson AR, Wade S, Goodnough T, Knight K, Dubois RW. Economic burden of anemia in an insured population. J Manag Care Pharm. (2005) 11:565–74. doi: 10.18553/jmcp.2005.11.7.565
7. Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE. (2014) 9:2–5. doi: 10.1371/journal.pone.0084943
8. Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, et al. Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities: an individual participant data metaanalysis in a global consortium. Am J Kidney Dis. (2019) 73:206–17. doi: 10.1053/j.ajkd.2018.08.013
9. Kovesdy, C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. Kidney international supplements. kisupplements.org.
10. Salokhiddinovna, X. Y. (2023). Anemia of Chronic Diseases. Research Journal of Trauma and Disability Studies, 2(12), 364-372. academiczone.net Lanser, L., Fuchs, D., Scharnagl, H., Grammer, T., Kleber, M. E., März, W., ... & Kurz, K. (2021). Anemia of chronic disease in patients with cardiovascular disease. Frontiers in Cardiovascular Medicine, 8, 666638. frontiersin.org
11. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306(5704):2090–2093. DOI: 10.1126/science.1104742.
12. Mazur A, Feillet-Coudray C, Romier B, et al. Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice. Metabolism 2003;52(10):1229–1231. DOI: 10.1016/S0026-0495(03)00277-4.
13. Shah YM, Xie L. Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology 2014;146(3):630–642. DOI: 10.1053/j.gastro.2013.12.031.Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE. (2014) 9:2–5. doi: 10.1371/journal.pone.0084943
14. Silvestri L, Pagani A, Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008;111(2):924–931. DOI: 10.1182/blood-2007-07-100677.-Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, et al. Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Comprehensive Journal of Science

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.








